These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10907682)

  • 1. Effect of glycosylation and glucose trimming inhibitors on the influenza A virus glycoproteins.
    Saito T; Yamaguchi I
    J Vet Med Sci; 2000 Jun; 62(6):575-81. PubMed ID: 10907682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive N-glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells.
    Pralow A; Hoffmann M; Nguyen-Khuong T; Pioch M; Hennig R; Genzel Y; Rapp E; Reichl U
    FEBS J; 2021 Aug; 288(16):4869-4891. PubMed ID: 33629527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of glycosylation in the functions and antigenic properties of influenza virus glycoproteins.
    Basak S; Compans RW
    Virology; 1983 Jul; 128(1):77-91. PubMed ID: 6192589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics.
    Wagner R; Wolff T; Herwig A; Pleschka S; Klenk HD
    J Virol; 2000 Jul; 74(14):6316-23. PubMed ID: 10864641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
    Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
    Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.
    Kim P; Jang YH; Kwon SB; Lee CM; Han G; Seong BL
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29642453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.
    Zhang J; Pekosz A; Lamb RA
    J Virol; 2000 May; 74(10):4634-44. PubMed ID: 10775599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y; Hardy I; Li Y; Boivin G
    J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhibitors of glycosylation on proteolytic activation of avian influenza virus hemagglutinins: discrimination between tryptic cleavage and elimination of the connecting peptide.
    Bosch FX; Orlich M; Legler G; Schwarz RT; Rott R
    Virology; 1984 Jan; 132(1):199-204. PubMed ID: 6695499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3.
    Tanaka Y; Kato J; Kohara M; Galinski MS
    Antiviral Res; 2006 Oct; 72(1):1-9. PubMed ID: 16730076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-influenza A virus activity of uridine derivatives of 2-deoxy sugars.
    Krol E; Wandzik I; Gromadzka B; Nidzworski D; Rychlowska M; Matlacz M; Tyborowska J; Szewczyk B
    Antiviral Res; 2013 Oct; 100(1):90-7. PubMed ID: 23911991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the development of the charge heterogeneity of the influenza virus glycoproteins.
    Bosch FX
    Arch Virol; 1985; 83(3-4):311-7. PubMed ID: 2982358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein.
    Gross V; Tran-Thi TA; Schwarz RT; Elbein AD; Decker K; Heinrich PC
    Biochem J; 1986 Jun; 236(3):853-60. PubMed ID: 2947571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol.
    Datema R; Romero PA; Legler G; Schwarz RT
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6787-91. PubMed ID: 6757922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
    Park S; Lee I; Kim JI; Bae JY; Yoo K; Kim J; Nam M; Park M; Yun SH; Cho WI; Kim YS; Ko YY; Park MS
    Biochem Biophys Res Commun; 2016 Oct; 479(2):192-197. PubMed ID: 27613087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
    Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
    PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains.
    Jing X; Phy K; Li X; Ye Z
    Vaccine; 2012 Jun; 30(28):4144-52. PubMed ID: 22561313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match.
    Kaverin NV; Gambaryan AS; Bovin NV; Rudneva IA; Shilov AA; Khodova OM; Varich NL; Sinitsin BV; Makarova NV; Kropotkina EA
    Virology; 1998 May; 244(2):315-21. PubMed ID: 9601502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.